Loading clinical trials...
Loading clinical trials...
A PHASE 1, RANDOMIZED, OPEN LABEL, 2-WAY CROSSOVER STUDY TO ESTIMATE THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE ORAL CONTRACEPTIVE STEROIDS IN HEALTHY FEMALE SUBJECTS
Conditions
Interventions
PF-06651600
Ethinyl estradiol (EE) and levonogestrel (LN)
Locations
2
United States
Quotient Sciences
Coral Gables, Florida, United States
Quotient Sciences-Miami, Inc.
Miami, Florida, United States
Start Date
September 21, 2018
Primary Completion Date
November 23, 2018
Completion Date
November 23, 2018
Last Updated
April 9, 2019
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions